J
José Cerbino-Neto
Researcher at Oswaldo Cruz Foundation
Publications - 28
Citations - 741
José Cerbino-Neto is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Medicine & Zika virus. The author has an hindex of 6, co-authored 17 publications receiving 558 citations. Previous affiliations of José Cerbino-Neto include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Zika virus evolution and spread in the Americas
Hayden C. Metsky,Hayden C. Metsky,Christian B. Matranga,Shirlee Wohl,Shirlee Wohl,Stephen F. Schaffner,Stephen F. Schaffner,Catherine A. Freije,Catherine A. Freije,Sarah M. Winnicki,Kendra West,James Qu,Mary Lynn Baniecki,Adrianne Gladden-Young,Aaron E. Lin,Aaron E. Lin,Christopher Tomkins-Tinch,Simon Ye,Simon Ye,Daniel J. Park,Cynthia Y. Luo,Cynthia Y. Luo,Kayla G. Barnes,Kayla G. Barnes,Rickey R. Shah,Rickey R. Shah,Bridget Chak,Bridget Chak,Giselle Barbosa-Lima,Edson Delatorre,Yasmine Rangel Vieira,Lauren M. Paul,Amanda L Tan,Carolyn M. Barcellona,Mario C. Porcelli,Chalmers Vasquez,Andrew C. Cannons,Marshall R. Cone,Kelly N. Hogan,Edgar W. Kopp,Joshua J. Anzinger,Kimberly García,Leda Parham,Rosa Margarita Gelvez Ramirez,Maria Conseulo Miranda Montoya,Diana Patricia Rojas,Catherine M. Brown,Scott Hennigan,Brandon Sabina,Sarah Scotland,Karthik Gangavarapu,Nathan D. Grubaugh,Glenn Oliveira,Refugio Robles-Sikisaka,Andrew Rambaut,Andrew Rambaut,Lee Gehrke,Lee Gehrke,Sandra Smole,M. Elizabeth Halloran,M. Elizabeth Halloran,Luis Angel Villar,Salim Mattar,Ivette Lorenzana,José Cerbino-Neto,Clarissa Valim,Clarissa Valim,Wim Degrave,Patrícia T. Bozza,Andreas Gnirke,Kristian G. Andersen,Kristian G. Andersen,Sharon Isern,Scott F. Michael,Fernando A. Bozza,Thiago Moreno L. Souza,Irene Bosch,Nathan L. Yozwiak,Nathan L. Yozwiak,Bronwyn MacInnis,Bronwyn MacInnis,Pardis C. Sabeti +81 more
TL;DR: It is found that ZIKV circulated undetected in multiple regions for many months before the first locally transmitted cases were confirmed, highlighting the importance of surveillance of viral infections.
Journal ArticleDOI
Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum
Irene Bosch,Irene Bosch,Helena de Puig,Megan Hiley,Marc Carré-Camps,Federico Perdomo-Celis,Carlos F. Narváez,Doris M. Salgado,Dewahar Senthoor,Madeline O’Grady,Elizabeth J. Phillips,Ann Durbin,Ann Durbin,Diana Fandos,Hikaru Miyazaki,Chun-Wan Yen,Margarita Gélvez-Ramírez,Rajas V. Warke,Lucas S. Ribeiro,Mauro M. Teixeira,Roque P. Almeida,José Esteban Muñoz-Medina,Juan E. Ludert,Maurício Lacerda Nogueira,Tatiana Elias Colombo,Ana Carolina Bernardes Terzian,Patrícia T. Bozza,Andrea Surrage Calheiros,Yasmine Rangel Vieira,Giselle Barbosa-Lima,Alexandre Gomes Vizzoni,José Cerbino-Neto,Fernando A. Bozza,Thiago Moreno L. Souza,Monique R.O. Trugilho,Ana Maria Bispo de Filippis,Patrícia Carvalho de Sequeira,Ernesto T. A. Marques,Ernesto T. A. Marques,Tereza Magalhaes,Tereza Magalhaes,Francisco J. Díaz,Berta Nelly Restrepo,Katerine Marín,Salim Mattar,Daniel G. Olson,Edwin J. Asturias,Mark Lucera,Mohit Singla,Guruprasad R. Medigeshi,Norma de Bosch,Justina O. Tam,Jose Gomez-Marquez,Charles R. Clavet,Luis Angel Villar,Kimberly Hamad-Schifferli,Kimberly Hamad-Schifferli,Lee Gehrke,Lee Gehrke +58 more
TL;DR: The characterization of monoclonal antibody pairs that have been translated into rapid immunochromatography tests to specifically detect the viral nonstructural 1 (NS1) protein antigen and distinguish the four DENV serotypes (DENV1–4) and ZIKV without cross-reaction are reported.
Journal ArticleDOI
Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015.
José Cerbino-Neto,Emersom Cicilini Mesquita,Thiago Moreno L. Souza,Viviane Parreira,Bernardo Bastos Wittlin,Betina Durovni,Maria Cristina Ferreira Lemos,Alexandre Gomes Vizzoni,Ana Maria Bispo de Filippis,Simone Alves Sampaio,Bianca de Santis Gonçalves,Fernando A. Bozza +11 more
TL;DR: The frequency of signs and symptoms from a sample of clinic patients in Rio de Janeiro, Brazil, who were later confirmed to have Zika virus disease by using real-time reverse transcription PCR (rRT-PCR), found rash to be the most common symptom for which patients sought care.
Journal ArticleDOI
Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection
Thiago Moreno L. Souza,Yasmine Rangel Vieira,Edson Delatorre,Giselle Barbosa-Lima,Raul Leal Faria Luiz,Alexandre Gomes Vizzoni,Komal Jain,Milene Mesquita,Nishit Bhuva,Jan F. Gogarten,Jan F. Gogarten,Jan F. Gogarten,James Ng,Riddhi Thakkar,Andrea Surrage Calheiros,Ana Paula T. Monteiro,Patrícia T. Bozza,Fernando A. Bozza,Diogo A. Tschoeke,Luciana Leomil,Marcos Cesar Lima de Mendonça,Cintia Damasceno dos Santos Rodrigues,Maria C. Torres,Ana Maria Bispo de Filippis,Rita Maria Ribeiro Nogueira,Fabiano L. Thompson,Fabiano L. Thompson,Cristina Lemos,Betina Durovni,José Cerbino-Neto,Carlos M. Morel,W. Ian Lipkin,Nischay Mishra +32 more
TL;DR: The observation that the ECSA genotype of CHIKV was circulating undetected underscores the need for improvements in molecular methods for viral surveillance.
Journal ArticleDOI
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Lulu Bravo,Igor Smolenov,Htay Htay Han,Ping Li,Romana Hosain,Frank W. Rockhold,Sue Ann Costa Clemens,Camilo C. Roa,Charissa Borja-Tabora,Antoinette Quinsaat,Pio Lopez,Eduardo López-Medina,Leonardo Brochado,Eder A Hernández,Humberto Reynales,T. Medina,Hector Velásquez,Leonardo Bautista Toloza,Edith Johana Rodriguez,Dora Ines Molina de Salazar,Camilo N. Rodríguez,Eduardo Sprinz,José Cerbino-Neto,Kleber Giovanni Luz,Alexandre Vargas Schwarzbold,Maria Sanali Moura de Oliveira Paiva,Josefina Carlos,May Montellano,Mari Rose De Los Reyes,Charles Yu,Edison Alberto,Mario M. Panaligan,Milagros S. Salvani‐Bautista,E. Buntinx,Maya Hites,Jean-Benoit Martinot,Q E Bhorat,Aysha Badat,Carmen Baccarini,Branda Hu,Jaco C J Jurgens,Jan-At Engelbrecht,Donna M. Ambrosino,Peter Richmond,George R. Siber,Joshua G. Liang,Ralf Clemens +46 more
TL;DR: Two doses of SCB-2019 vaccine plus CpG and alum provides notable protection against the entire severity spectrum of COVID-19 caused by circulating SAR-CoV-2 viruses, including the predominating delta variant.